These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7503626)

  • 1. Cladribine (2-chloro-2'-deoxyadenosine): new perspectives in clinical immunosuppression.
    Górski A; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):11-2. PubMed ID: 7503626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, mechanism and expected clinical significance of selective cytotoxicity of 2-chloro-2'-deoxyadenosine (2-CdA).
    Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):1-5. PubMed ID: 7503624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro.
    Górski A; Grieb P; Korczak-Kowalska G; Wierzbicki P; Stepień-Sopniewska B; Mrowiec T
    Immunopharmacology; 1993; 26(3):197-202. PubMed ID: 7904595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Chloro-2-deoxyadenosine--a novel immunosuppressive agent.
    Górski A; Grieb P; Makula J; Stepień-Sopniewska B; Mrowiec T; Nowaczyk M
    Transplantation; 1993 Nov; 56(5):1253-7. PubMed ID: 7902627
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506).
    Nowaczyk M; Stephień-Sopniewska B; Korczak-Kowalska G; Mrowiec T; Górski A
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):329-32. PubMed ID: 8744655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Chloro-2'-deoxyadenosine (2-CdA) combined with cyclosporine A successfully prevents rejection of fetal brain stem allograft in rabbits.
    Grieb P; Ryba M; Janczewski W; Sawicki J; Jagielski J; Andrychowski J
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):43-6. PubMed ID: 7503634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
    Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Chloro-2'-deoxyadenosine (2-CdA) treatment in a patient with Waldenström's macroglobulinaemia complicated by severe neutrocytopenia.
    Zaucha JM; Ciesielski D; Grieb P; Hellmann A
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):35-7. PubMed ID: 7503632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis.
    Davis JC; Austin H; Boumpas D; Fleisher TA; Yarboro C; Larson A; Balow J; Klippel JH; Scott D
    Arthritis Rheum; 1998 Feb; 41(2):335-43. PubMed ID: 9485092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural changes of retinal ganglion cells in rabbits of New Zealand breed after experimental administration of 2-CDA (Cladribine).
    Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):381-6. PubMed ID: 12898866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of lymphocyte-fibroblast interactions by 2-chloro-2'-deoxyadenosine (2-CdA) in subarachnoid hemorrhage.
    Ryba M; Grieb P; Majewski S; Makieła B; Pastuszko M; Andrychowski J; Bojarski P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):47-9. PubMed ID: 7503635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of multiple sclerosis with cladribine (2-CDA), a new immunosuppressant agent. Theoretical basis and preliminary results].
    Grieb P; Stelmasiak Z
    Neurol Neurochir Pol; 1995; 29(1):69-76. PubMed ID: 7596480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of 2-chloro-2'-deoxyadenosine (2-CdA).
    Zahorska R; Mazur N; Skierski JS; Grieb P
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):137-41. PubMed ID: 8915519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the ERK pathway promotes apoptosis induced by 2-chloro-2'-deoxyadenosine in the B-cell leukemia cell line EHEB.
    Smal C; Lisart S; Ferrant A; Bontemps F; van den Neste E
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1009-12. PubMed ID: 17065055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
    Fabianowska-Majewska K; Wyczechowska D
    Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
    Góra-Tybor J; Robak T
    Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB.
    Smal C; Lisart S; Maerevoet M; Ferrant A; Bontemps F; Van Den Neste E
    Biochem Pharmacol; 2007 Feb; 73(3):351-8. PubMed ID: 17137556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Chloro-2'-deoxyadenosine--clinical, biochemical and pharmacokinetic considerations.
    Liliemark J; Juliusson G
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):7-10. PubMed ID: 7503639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cladribine for multiple sclerosis: review and current status.
    Sipe JC
    Expert Rev Neurother; 2005 Nov; 5(6):721-7. PubMed ID: 16274330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cladribine therapy in refractory celiac disease with aberrant T cells.
    Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.